With the growing importance of “big data” and data science in genomics (and, increasingly, across all biomedical research), NHGRI sought to formalize and optimize its data science strategy. In this role, she will provide leadership, strategic guidance, and coordination for the Institute’s activities, programs, and policies in genomic data science. In December 2021, Valentina Di Francesco, M.S., began a new role as NHGRI’s first Chief Data Science Strategist and Founding Director of the new NHGRI Office of Genomic Data Science. Tabak had served as the Principal Deputy Director since August 2010.Īs we move into 2022, stay safe and healthy! Meanwhile, Francis Collins, M.D., Ph.D., has stepped down as the NIH Director, and Larry Tabak, D.D.S., Ph.D., is now serving as the Acting NIH Director. This allows NIH to continue to fund ongoing research at grantee institutions and maintain operations within its Intramural Research Program. While we look forward to the approval of an official federal budget for Fiscal Year 2022, the CR allows NIH to operate at a budget level at or below the federal budget for Fiscal Year 2021. I encourage you to read the University of Washington’s obituary for Debbie, which can be found here.Īt NIH, we start 2022 under a continuing resolution (CR), which has the government operating through February 18, 2022. She was a cherished NHGRI grantee, advisor, and friend - she will be sorely missed. I had known and admired Debbie for more than three decades, starting before the launch of the Human Genome Project. The Omicron SARS-CoV-2 variant dampened efforts to put the COVID-19 pandemic behind us, and the genomics community lost one of its shining stars - Debbie Nickerson - on Christmas Eve. While we are all working hard to bring an optimistic outlook to the new year, 2021 ended on a somber note.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |